PF-Atlas › Clinical Trials › NCT03076320

Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne

PDF+M-DDO · Phase 1

Registry ID

NCT03076320

Phase

Phase 1

Status

Completed

Drug / intervention

PDF+M-DDO

Sponsor

University of Guadalajara

Start

2017-03-27

About this trial

PDF+M-DDO is evaluated in NCT03076320, a Phase 1 idiopathic pulmonary fibrosis study sponsored by University of Guadalajara. Current status: Completed.

View NCT03076320 on ClinicalTrials.gov →

Explore related

All PDF+M-DDO trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT03076320 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.